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Background: Skin resident microbial species are often thought of either as pathogenic or commensal. However, little is
known about the role of the skin barrier in modulating their potential for causing disease. To investigate this question we
measured the effects of three microbial species commonly found on the skin (Staphylococcus epidermidis, Staphylococcus
aureus, and Propionibacterium acnes) on a reconstructed human epidermal model by either applying the bacteria on
the model surface (intact barrier) or adding them to the culture medium (simulating barrier breach).
Results: When added to the medium, all of the tested species induced inflammatory responses and keratinocyte cell
death with species-specific potency. P. acnes and S. epidermidis induced specific alterations in the expression of
keratinocyte differentiation and proliferation markers, suggesting a barrier reparation response. S. aureus induced
complete keratinocyte cell death. On the contrary, topically applied S. epidermidis and P. acnes caused no inflammatory
response even when tested at high concentrations, while topical S. aureus induced a weak reaction. None of the tested
species were able to alter the expression of keratinocyte differentiation or expression markers, when applied topically.
Conclusions: We show that the skin barrier prevents the effects of common skin bacteria on epidermal keratinocyte
inflammation, differentiation and proliferation and highlight the importance of skin barrier in defending against the
pathogenic effects of common skin bacteria.
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In the last few years it has been conclusively demonstrated
that the human skin is an important part of the innate
immune system, acting as a first barrier against external
microbial threats. In response to pathogenic insults, epider-
mal keratinocytes secrete an array of soluble cytokines
and chemokines to initiate an active immune response
[1]. A number of innate defensive pathways are activated,
including the generation of reactive oxygen bursts [2,3]
and the secretion of human β-defensin, cathelicidin and
RNase-family antimicrobial peptides [3].* Correspondence: GStamata@its.jnj.com
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reproduction in any medium, provided the orIt is becoming increasingly accepted that commensal
species of micro-organisms that naturally reside on the
surface of the human skin are an integral part of the innate
immune system. For example, Staphylococcus epidermidis,
the most common cutaneous bacteria, secretes antimicro-
bial phenol-soluble modulins [4], while stimulating se-
cretion of antimicrobial peptides from keratinocytes,
providing increased resistance to pathogen infection [5].
Colonization of the skin by the common microflora may
assist in training the developing adaptive immune system
by providing epitopes against which the immune system
can become primed [6,7]. S. epidermidis for example,
controls cutaneous immune responses by modulating
local T-effector cells through the IL-1 pathway, establish-
ing resistance to infection [8]. The compositions of speciesal Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ation with the physiological conditions of the skin micro-
environment [9]. Furthermore, the composition of the
human skin microflora matures following birth and
throughout infancy [6] and possibly through puberty,
as the human skin matures in terms of sebaceous activity
[10], surface water content [11] and skin surface pH [12].
It could be expected that the skin adjusts its physiological
conditions to favor colonization by commensal microflora
species over pathogenic species during this period.
However, the same commensal microbial species are
also implicated in the pathogenesis of cutaneous infections
under altered micro-environmental conditions or when
able to overcome the host immune systems [13], as well
as in proinflammatory diseases such as acne vulgaris [14],
atopic dermatitis [15], and psoriasis [16]. Upon penetration
of the skin barrier, members of the skin microflora have
been known to elicit diseases such as impetigo, cellulitis,
and systemic diseases including endocarditis and sepsis
[17]. Knowledge of the immunological interactions between
the skin keratinocytes and the skin microflora is imperative
in understanding the role of the skin microflora in immune
protection and pathogenesis, as well as the factors that
determine the commensal or pathogenic nature of the
skin microbiome.
During the first years of life, the barrier function and
microstructure of infant skin continue to mature [11,18].
It is possible that the early colonization of the skin by
commensal bacteria and the subsequent maturation of
microbial colony compositions [6] may influence the
correct development of the epidermis following birth.
Microbial-induced effects on keratinocyte differentiation
and proliferation have been observed previously: P. acnes
has been shown to stimulate normal human epidermal
keratinocyte (NHEK) proliferation and affect expression
of the differentiation markers Filaggrin, β1 Integrin [19],
Transglutaminases 1, 3 and 5, and Keratins 1, 10 and 17
[20]. The ability of members of the skin microbiome to
modify epidermal keratinocyte properties and the co-
maturation of infant epidermal properties with microflora
species composition over time may suggest that the
skin microflora may be important for skin maturation
in early life.
The top layer of human skin, the stratum corneum,
presents a physical barrier to microbial migration through
the skin. To investigate the importance of the skin barrier
in modulating the effects of the skin microflora on the
human epidermis, we applied three species of common
skin colonizers to the Reconstructed Human Epidermis
(RHE) model. The model consists of stratified human
epidermal keratinocytes, complete with stratum corneum,
making it relevant to test the interactions of microorgan-
isms residing topically or that have penetrated the skin
barrier. In this report we investigated the effects of topicaland subcutaneous S. epidermidis, S. aureus and P. acnes,
on the elicitation of keratinocyte inflammatory responses
and the differentiation and proliferation of the RHE
keratinocytes. We demonstrate the effects of species-
specific responses and discuss how epidermal keratinocytes
are impacted by and respond to the skin microflora as resi-
dent inhabitants of the skin surface and as opportunistic
pathogens when the barrier is breached.
Results
Effects of bacteria added in the medium (breached
barrier model) on keratinocyte inflammation and viability
We tested the effects of bacteria added to the RHE
medium, essentially underneath the RHE keratinocytes in
order to mimic a scenario in which the bacteria had pene-
trated the epidermal barrier. Following treatment, the
RHE culture medium was screened for pro-inflammatory
cytokines and LDH as previously described. All of the
tested species induced significant increases in the release of
pro-inflammatory cytokines from the RHE keratinocytes
and LDH (Figures 1, 2), indicating a pro-inflammatory
and cytotoxic effect of the bacteria upon breaching of the
epidermal barrier. We observed differential inflammatory
and cytotoxic potency between species: P. acnes for ex-
ample was least potent, inducing statistically significant
increases in pro-inflammatory cytokine and LDH release
only at the highest concentration tested. S. epidermidis
had a greater pro-inflammatory and cytotoxic effect upon
the RHE keratinocytes than P. acnes, inducing greater
relative increases in cytokine and LDH release at each
tested concentration, and induced statistically significant
increases in cytokine and LDH release at lower concen-
trations than P. acnes (Figure 1). S. aureus was the most
cytotoxic and pro-inflammatory of the species added to
the RHE medium and stimulated a large and statistically
significant increase in IL-1α and LDH release when added
at just 1 × 107 CFU (Figure 2). Higher concentrations of S.
aureus did not elicit greater increases in LDH, suggesting
that maximal RHE keratinocyte cell death had been
induced. S. aureus was even able to stimulate statistically
significant increases in IL-1α and LDH release when added
to the RHE medium at 1 × 102 CFU (data not shown),
showing that it is highly cytotoxic. All RHEs treated with S.
aureus detached from their basement filters, indicating
total keratinocyte cell death. It is likely that the cytotoxicity
of S. aureus in the medium induced cell death, causing the
release of stored IL-1α before synthesis of IL-8 and TNFα
could occur and the levels of IL-8 and TNFα released
remained unaltered by S. aureus in the medium.
Effects of bacteria added in the medium (breached barrier
model) on keratinocyte differentiation and proliferation status
We studied the effects of bacteria added to the RHE











































































































































P. acnes S. epidermidis
Figure 1 P. acnes and S. epidermidis added to the medium of reconstructed human epidermal equivalents induce dose-dependent
proinflammatory and cytotoxic reactions. After 24 hrs incubation with bacteria at 1 × 107, 1 × 108 and 1 × 109 CFU, the interleukin (IL)-1α
(A), IL-8 (B) and TNFα (C) levels in the RHE growth medium were measured. The cell viability (D) was assessed by measuring leakage of
cytoplasmic Lactate Dehydrogenase (LDH) into the RHE growth medium. Data are expressed as percentage of untreated control (UnC = 100%) and are
presented as mean ± one standard deviation. Single and double asterisks indicate statistically significant differences (P < 0.05 and P < 0.01) versus the
untreated control.
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CLD and PCNA. Addition of S. aureus in the medium
induced keratinocyte cell death and degradation of marker
mRNA, making it impossible to collect useful data.
However, addition of P. acnes and S. epidermidis induced
common patterns of changes in gene expression indicating
a conserved response of the keratinocytes (Figure 3). In
both cases, adding the bacteria to the medium induced
decreased FLG and PCNA expression and increased OCCL
and TG1 expression. The expression of CLD was not
significantly affected by the presence of S. epidermidis
or P. acnes in the RHE growth medium. As observed with
the release of proinflammatory cytokines, S. epidermidis
induced a stronger response than P. acnes in the induction
of transcriptional changes of the RHE keratinocytes.
S. epidermidis was able to induce significant changes inthe expression of FLG, TG1, OCCL and PCNA when
tested at only 1 × 107 CFU, whereas P. acnes was only able
to induce significant increases in the affected differentiation
markers at 1 × 109 CFU and PCNA at 1 × 108 CFU.
Effects of topically applied bacteria (intact barrier model)
on keratinocyte inflammation and viability
We then tested the potential of topically applied S. epider-
midis, P. acnes, and S. aureus to induce proinflammatory
cytokine release and cell death in human epidermal kerati-
nocytes. Twenty four hours after treatment of RHEs with
topically applied bacteria, RHE culture medium was taken
and levels of the proinflammatory cytokines IL-1α, IL-6,
IL-8, and TNFα, as well as LDH were quantified to meas-
ure epidermal inflammation and cell death respectively.



















































































































Figure 2 S. aureus added to the medium of reconstructed human epidermal equivalents induces strong proinflammatory and
cytotoxic reactions. After 24 hrs incubation with bacteria at 1 × 107, 1 × 108 and 1 × 109 CFU, the interleukin (IL)-1α (A), IL-8 (B) and TNFα (C)
levels in the RHE growth medium were measured. The cell viability (D) was assessed by measuring leakage of cytoplasmic Lactate Dehydrogenase
(LDH) into the RHE growth medium. Data are expressed as percentage of untreated control (UnC = 100%) and are presented as mean ± one
standard deviation. Single and double asterisks indicate statistically significant differences (P < 0.05 and P < 0.01) versus the untreated control.
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keratinocytes when applied topically and induced little
change in IL-1α, IL-8 and TNFα release (Table 1). Topical
S. epidermidis at 1 × 109 CFU induced a statistically sig-
nificant increase in IL-8 release compared to the untreated
series (P = 0.05). However, the magnitude of this increase
could be considered negligible and was elicited only at
high bacterial concentrations. Neither species appeared
to have cytotoxic effects on the RHE keratinocytes, based
on the levels of LDH recovered from the RHE culture
medium. S. aureus stimulated release IL-1α from the RHE
keratinocytes when topically applied only at high concen-
trations (1 × 108 and 1 × 109 CFU). This was observed in
some RHE replicates, but not others, accounting for the
high variability observed in the data. Coinciding with this,
we also observed large increases in LDH release stimu-
lated in these same replicates. It is likely that topically
applied S. aureus at 1 × 108 and 1 × 109 CFU induced
keratinocyte cell death and subsequent release of storedIL-1α [21], before synthesis of IL-8 and TNFα could occur.
No IL-6 was detected in the growth medium of the un-
treated or treated series.
Effects of topically applied bacteria (intact barrier model)
on keratinocyte differentiation and proliferation
Finally, we tested whether topically applied S. epidermidis,
P. acnes and S. aureus could affect the differentiation and
proliferation of RHE keratinocytes. S. epidermidis and P.
acnes were tested at 1 × 107, 1 × 108, and 1 × 109 CFU, while
S. aureus was tested at 1 × 103, 1 × 105, and 1 × 107 CFU as
its cytotoxicity at high concentrations caused degradation
of mRNA prohibiting further genetic analysis. The kera-
tinocyte expression of the differentiation markers FLG
(Profilaggrin), TG1 (Transglutaminase-1), CLD (Claudin-1)
and OCCL (Occludin), as well as the proliferation marker
PCNA (Proliferating Cell Nuclear Antigen), were measured
following topical treatment with the tested species. None









































































































Figure 3 (A) S. epidermidis and (B) P. acnes added to the medium of reconstructed human epidermal equivalents induce dose-dependent
changes in the expression of genes involved in differentiation (FLG, TG1, CLD, OCCL) and proliferation (PCNA). After 24 hrs incubation with
bacteria at 1 × 107, 1 × 108 and 1 × 109 CFU, RNA from the RHEs was extracted and reverse transcribed. The mRNA expression levels of a range of
genes were determined by quantitative reverse transcription polymerase chain reaction. The amount of target transcripts was normalized using an 18S
RNA normalization gene. Data are expressed as percentage of untreated control (UnC = 100%) and are presented as mean ± one standard deviation.
Asterisks indicate statistically significant differences (P < 0.05) vs the untreated control.
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tion markers at the tested concentrations (Table 2).Discussion
In this study we investigated whether the physical barrier
presented by the stratum corneum is sufficient to inhibit
microbial-induced effects on epidermal inflammation,
differentiation, and proliferation status. Three bacterial
species commonly found on the human skin surface (P.
acnes, S. epidermidis and S. aureus) were tested for their
effects on human epidermal keratinocytes in a stratified
in vitro model. We show that bacteria introduced into
the RHE medium (below the epidermal barrier) inducedimportant changes whereas bacteria applied topically
had little effect on the RHE keratinocytes.
Topically applied P. acnes and S. epidermidis did not
elicit significant inflammatory responses from the RHE
keratinocytes and displayed no cytotoxicity. Both P. acnes
and S. epidermidis can be considered on one hand as
commensal species, while on the other as opportunistic
pathogens implicated in inflammatory diseases. Our data
suggest that P. acnes and S. epidermidis are unlikely to
contribute to the pathogenesis of inflammatory conditions
when residing on top of the skin barrier: especially as these
species were tested at concentrations orders of magnitude
above the concentrations of between 3 and 6 CFU normally
expected on healthy skin [22]. S. aureus however did
Table 1 Average release of the proinflammatory cytokines IL-1α, IL-8, TNFα (pg/ml) and LDH (measured by optical
absorbance at 490 nm) from RHE 24 hours after topical treatment with S. epidermidis, P. acnes and S. aureus at
different concentrations
Untreated control 1×107 CFU 1×108 CFU 1×109 CFU
S. epidermidis
[IL-1α] released 100 ± 3.5 116 ± 111.2 143.6 ± 156.8 186.8 ± 215.8
[IL-8] released 100 ± 18.4 151.7 ± 248.8 118.9 ± 156 193.4 ± 239.5*
[TNFα] released 100 ± 0.6 124.4 ± 35.6 138 ± 77.1 151.8 ± 80.7
LDH absorbance 100 ± 0.03 83.6 ± 63.2 82.6 ± 62.9 88.6 ± 58.2
P. acnes
[IL-1α] released 100 ± 8.28 123.1 ± 100.3 122 ± 91 133.4 ± 112.1
[IL-8] released 100 ± 42.08 120.7 ± 129.6 109.5 ± 97.3 107.1 ± 84.9
[TNFα] released 100 ± 1.6 162.6 ± 158.1 115.7 ± 126.1 88.6 ± 113.6
LDH absorbance 100 ± 0.04 100.2 ± 148.4 108.8 ± 161.6 102.1 ± 142.8
S. aureus
[IL-1α] released 100 ± 2.3 157.6 ± 303.8 1062.1 ± 3556.2 1251.7 ± 3735.6
[IL-8] released 100 ± 12.1 60.4 ± 27.7 93.1 ± 95.1 73 ± 2.6
LDH absorbance 100 ± 0.1 273.3 ± 357.5 505.2 ± 1002 666.4 ± 1321
Results are expressed as percentage of the untreated control.
*Single asterisk indicate statistically significant differences (P < 0.05) versus the untreated control.
Table 2 Average expression of the RHE differentiation
markers FLG, TG1, CLD, OCCL and the proliferation
marker PCNA (measured as % expression of untreated
control) 24 hours after topical treatment with S.




1×107 CFU 1×108 CFU 1×109 CFU
S. epidermidis
FLG 100 ± 21.1 105 ± 50.5 113 ± 60 99 ± 37.4
TG1 100 ± 11 95 ± 30.7 95 ± 33.5 92 ± 25.8
CLD 100 ± 29.2 142 ± 68.3 161 ± 105.2* 123 ± 53.5
OCCL 100 ± 17.2 84 ± 30.9 95 ± 35.4 113 ± 63.8
PCNA 100 ± 25.3 129 ± 36.2 120 ± 39.2 135 ± 34*
P. acnes
FLG 100 ± 28 110 ± 26.5 101 ± 42 99 ± 31.4
TG1 100 ± 26.9 125 ± 74.7 84 ± 29.9 77 ± 34.6
CLD 100 ± 36.5 90 ± 35.7 71 ± 32.1* 84 ± 31.6
OCCL 100 ± 33.4 112 ± 72.9 81 ± 40.5 97 ± 42.6
PCNA 100 ± 18.6 102 ± 49.4 132 ± 108.2 140 ± 93.9
S. aureus 1×103 CFU 1×105 CFU 1×107 CFU
FLG 100 ± 19.3 121 ± 32.6 107 ± 20.5 141 ± 45.9
TG1 100 ± 12 179 ± 65.8 112 ± 31.7 114 ± 34.3
CLD 100 ± 22.4 107 ± 25.3 126 ± 30.2 141 ± 43.8*
OCCL 100 ± 31.9 139 ± 67.7 141 ± 43.9 143 ± 45.7*
PCNA 100 ± 18 104 ± 22.6 98 ± 14.3 97 ± 48
*Single asterisk indicate statistically significant differences (P < 0.05) versus the
untreated control.
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in some replicates when tested at high concentrations.
However, it is unlikely that concentrations of S. aureus
would reach these values on top of human skin in vivo,
unless the bacteria could overpower a weakened immune
system. We also note that none of the tested species were
able to alter keratinocyte differentiation or proliferation
and our data suggest that topically residing skin bacteria
cannot influence the development of the human skin. The
barrier posed by the stratum corneum of the RHE model
is likely to have prevented the contact and interaction of
the tested bacteria with the living RHE keratinocytes, and
may prevent the topical skin microflora affecting living
keratinocytes in vivo. S. aureus however, has been shown
to be able to circumvent the stratum corneum barrier
in the pathogenesis of diseases such as scalded skin
syndrome [23], which may account for the inflammatory
effects it induced when topically applied to the RHE
models.
When added to the RHE growth medium, the tested
species had a large impact on the RHE keratinocytes. P.
acnes and S. epidermidis were able to induce large inflam-
matory responses from the RHE keratinocytes and were
highly cytotoxic. These effects were stronger when induced
by S. epidermidis. P. acnes and S. epidermidis are known
to cause infection when introduced to the subcutaneous
space by prostheses or catheters that penetrate the skin
[17]. In these situations, the concentrations of P. acnes
or S. epidermidis underneath the skin barrier could equal
those tested in this experiment and cause large-scale
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complete keratinocyte cell death and subsequent IL-1α
release even when tested at low concentrations, indicating
the highly pathogenic potential of S. aureus upon penetra-
tion of the skin barrier.
Specific transcriptional changes in keratinocyte marker
expression were also induced when the skin bacteria
were added to the RHE culture medium. P. acnes and S.
epidermidis induced identical expression profiles in the
keratinocyte markers that appeared to indicate an effort to
repair the epidermal barrier function. We observed large
increases in the expression of TG1 in RHE keratinocytes
treated with P. acnes and S. epidermidis in the medium.
Transglutaminase-mediated crosslinking of protein scaffold
networks is an important step in epidermal keratinocyte
terminal differentiation, which results in the formation of
the stratum corneum barrier (reviewed by Eckert et al. [24])
and the upregulation of TG1 suggests an increased effort to
improve epidermal barrier function by the keratinocytes. It
is therefore surprising that expression of FLG was
downregulated by the bacterial treatment: FLG monomer
binding to keratin filaments organizes them into bundles,
establishing a protein network that forms the cornified
envelope and stratum corneum [25]. Recently however,
de Koning et al. [26] observed identical transcriptional
changes in FLG and TG1 during epidermal barrier repair,
corroborating the hypothesis that P. acnes and S. epidermi-
dis stimulated barrier repair processes in RHE keratinocytes
when added to the medium. de Koning et al. [26] speculate
that FLG may be involved in epidermal barrier mainten-
ance, as opposed to repair and is subsequently downregu-
lated as focus is shifted to repair. The tight junction protein
OCCL was significantly upregulated by the bacterial treat-
ments, which may indicate an effort of the keratinocytes to
improve barrier function through tightening of cell-to-cell
contacts. However, we did not observe altered expression
of the tight junction protein CLD. It may instead be that
OCCL is a degradation target for these bacteria and is
upregulated in expression to compensate: OCCL has been
shown to be degraded during staphylococcal infection
previously [27]. We also observed large decreases in
the expression of the proliferation marker, PCNA. One
might expect the proliferation rate of RHE keratinocytes
treated with bacteria to increase in order to mount an
amplified immune response. However, it seems that the
RHE keratinocytes favored differentiation and barrier
repair over regeneration and proliferation. The specific
transcriptional changes induced by bacteria introduced
below the RHE epidermal barrier were identical between
the tested species and matched previously described
profiles elicited in response to barrier disruption [26].
It is possible that epidermal keratinocytes recognize
the presence of the bacteria as a barrier disruption sig-
nal, as opposed to a scenario in which the microfloraare able to modulate gene transcription in epidermal
keratinocytes.
In this work we modeled epidermal breach by intro-
ducing bacteria to the medium of RHE. This is a first
approach to understand skin barrier breach. A more
realistic approach could be by damaging the barrier e.g. by
scratching or tape stripping. These methods would be
valuable for an in vivo setting and cannot be applicable
and reproducible for the in vitro RHE model. However,
the number of measured parameters in vivo would be
limited, unless an invasive biopsy would be used with
the associated problems (e.g. inflammatory markers will
increase due to the invasive nature of the biopsy).
Another potential limitation of the study is that we used
ATCC strains that could likely have distanced genetically
from actual human skin bacteria. Isolation of microbial
strains collected from human skin is going to be tried in
the future on this model. However, genetic variability of
such strains between hosts or even between body sites of
the same host needs also to be considered.
Our data suggest that topically residing bacteria must
be able to penetrate the epidermal barrier in order to affect
the activities of epidermal keratinocytes. The human
skin microflora has been shown to offer protective im-
munological benefits against pathogens both directly
[4] as well as indirectly by interacting with human skin
keratinocytes [5,28]. One scenario of this could be seen
during wounding in which S. epidermidis is granted access
to epidermal keratinocytes and can modulate their immune
response [28]. However it is hard to envisage the topical
skin microflora having these effects if prevented from
interacting with the epidermal keratinocytes by the stratum
corneum. We mentioned above the possibility that the
skin microflora may provide epitopes to prime the immune
system against pathogens following birth [6-8] and the
possibility that this early colonization could stimulate
the maturation of the skin barrier following birth. It is
possible that the skin microflora may be able to interact
with epidermal keratinocytes during this period and enter
the epidermis via hair follicles and other epidermal ap-
pendages [7]. The diverse ways by which topically residing
commensals may be able to interact with epidermal kerati-
nocytes remain to be explored.
Conclusions
Based on the observed data, P. acnes, S. epidermidis and
S. aureus were unable to modulate the inflammatory,
differentiation and proliferation status of RHE keratino-
cytes when applied topically. When tested on a breached
skin barrier model, P. acnes and S. epidermidis induced
strong inflammatory responses from RHE keratinocytes
and induced specific changes in the expression of RHE
keratinocyte differentiation and proliferation markers,
perhaps indicative of a barrier repair response. S. aureus
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proinflammatory cytokines when tested even at low con-
centrations. Together, our data show that these species of
common skin bacteria are prevented from affecting human
epidermal keratinocytes by the stratum corneum when
residing topically, but may contribute to the pathogenesis
of inflammatory diseases following penetration of the skin
immunity barrier. The skin barrier is therefore an import-
ant part of the innate immune system’s defence against the
pathogenic effects of common skin bacteria.
Methods
Preparation of bacteria
P. acnes (ATCC strain 6919) from second passage stock
at -80°C was plated on tryptic soy agar for 5 days at 37°C in
anaerobic conditions to yield third passage bacteria and
was repeated to yield fourth passage bacteria. S. epidermidis
(ATCC strain 12228) and S. aureus (ATCC strain 6538)
were taken from second passage stock at -80°C and were
plated on tryptic soy agar for 48 hrs at 32°C in aerobic
conditions to yield third passage bacteria, and again to
yield fourth passage bacteria. Each species of bacteria
was suspended in both physiological water and RHE
growth medium at 1 × 109 Colony Forming Units (CFU),
as estimated by the optical density of the solutions, and
confirmed by standard plate count.
Reconstructed human epidermis (RHE)
RHE tissues were purchased from Skinethic, Lyon, France.
Upon delivery, RHE inserts were transferred to 1 ml RHE
growth medium free of antibiotics and hydrocortisone.
Inserts were incubated for 24 hrs at 37°C and 5% CO2 in
sterile conditions.
For the subcutaneous treatment, RHE inserts were trans-
ferred to wells containing 1 ml RHE growth medium con-
taining P. acnes, S. epidermidis or S. aureus at 1 × 107 CFU,Table 3 Sense and antisense primer sequences used in qPCR
Genetic marker





Proliferating cell nuclear antigen PCNA1 × 108 CFU and 1 × 109 CFU. For the untreated control,
RHE inserts were transferred to 1 ml RHE growth medium
without bacteria.
For the topical treatment, 20 μl of bacterial solution
containing 1 × 107 CFU, 1 × 108 CFU and 1 × 109 CFU
of P. acnes, S. epidermidis or S. aureus in physiological
solution was added directly on top of RHE inserts. For
the untreated control, 20 μl of physiological solution with-
out bacteria was applied instead. The solution applied as a
drop was then spread uniformly on the surface with a
sealed end Pasteur pipette.
For S aureus, lower concentrations (1 × 102, 1 × 103,
1 × 105 and 1 × 107 CFU) were also tested in the medium
as this species induces cell death at high concentrations.
All treated RHEs were incubated for 24 hrs at 37°C
and 5% CO2 before the RHE medium was collected and
frozen at -80°C and RNA was extracted. The represented
values are the mean and the standard deviation of at
least three to five independent experiments.Biochemical assays
Collected RHE growth medium was screened for Interleu-
kin (IL)-1α, IL-6, IL-8 and Tumor Necrosis Factor-α
(TNFα) using the Flourokine MAP Human Base Kit A
(R&D Systems, Lille, France) and analyzed on the Bioplex-
200 (Bio-rad, Marnes-la-Coquette, France).
Keratinocyte cell viability was estimated by measuring
leakage of cytoplasmic Lactate Dehydrogenase (LDH)
into the RHE growth medium using the TOX7-1KT
Lactate Dehydrogenase-based In-Vitro Toxicology Assay
Kit (Sigma-Aldrich, Saint Quentin Fallavier, France) with
the procedure provided by the manufacturer.
Results were expressed as percentage change in in-
flammation markers or in LDH absorbance at 490 nm,
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Each RHE epidermal tissue was physically separated from
the inert polycarbonate filter and lysed in 400 μl lysis buffer,
consisting of 100 parts RLT buffer (from the Fibrous Tissue
Mini Kit (50) (Qiagen, Courtaboeuf, France), to one part
2-Mercaptoethanol (Sigma-Aldrich) inside a ceramic bead
tube (Ozyme, Saint Quentin en Yvelines, France). The tubes
were shaken at 5000 rpm and RNA was extracted from
the solutions using the Fibrous Tissue Mini Kit (50) on
the automated RNA extraction unit; the Qiacube (Qiagen)
which eluted the samples in 60 μl RLT buffer.
Reverse transcription was performed with the High
Capacity Reverse Trancription Kit (Applied Biosystems,
Courtaboeuf, France) using 2 μl RT Buffer, 0.8 μl dNTP
mix, 2 μl 10 x RT random primers and 4.2 μl nuclease free
water per 10 μl sample. The RT reaction was performed at
25°C for 10 min 37°C for 2 hrs.
Quantitative Polymerase Chain Reaction (qPCR) was
used to screen for the expression of genes filaggrin
(FLG), transglutaminase 1 (TG1), occludin (OCCL), claudin
(CLD), and Proliferating Cell Nuclear Antigen (PCNA).
The specific primers used in the study are shown in Table 3.
The expression of these genes was normalized against
the expression of the 18S housekeeping gene. For each
PCR reaction, 5 μl DNA solution was added to 12.5 μl
Power SYBR Green PCR Master Mix (Applied Biosystems),
0.075 μl L-primer solution, 0.075 μl R-primer solution
(Sigma-Aldrich) and 7.35 μl nuclease free water. The reac-
tions were cycled in a 96-well PCR plate on the Mx3000p
Stratagene, (Agilent, Massy, France). Changes in expression
of a genetic marker were deemed significant if found to be
half or double that of the untreated control.Statistical analysis
Comparison of keratinocyte Interleukin release under test
conditions versus untreated control were performed using
the Student’s t-test at 95% significance level.Abbreviations
CFU: Colony forming units; CLD: Claudin; dNTP: Deoxyribonucleotide
phosphate; FLG: Filaggrin; IL-1α: Interleukin 1-alpha; IL-6: Interleukin-6;
IL-8: Interleukin-8; LDH: Lactose dehydrogenase; NHEK: Normal human
epidermal keratinocyte; OCCL: Occludin; PCNA: Proliferating cell nuclear
antigen; qPCR: Quantitative polymerase chain reaction; RHE: Reconstructed
human epidermis; RT: Reverse transcriptase; TG1: Transglutaminase-1;
TLR: Toll-like-receptor; TNFα: Tumour necrosis factor alpha.Competing interest
The authors are employees of Johnson & Johnson Santé Beauté France.Authors’ contributions
The experiments were designed by GS and TO and were carried out by PD,
with the exception of the preparation of bacterial solutions which was
performed by DY. The project was supervised by JS and HKW. PD prepared
the final manuscript, which was checked and approved by all authors.Acknowledgements
The authors would like to thank Christelle Fécourt for her technical
assistance with the qPCR experiment. This study was fully funded by
Johnson & Johnson Santé Beauté France.
Author details
1Durham University, School of Biological and Biomedical Sciences, South
Road, Durham DH1 3LE, United Kingdom. 2Johnson & Johnson Santé Beauté
France, Campus de Maigremont, Val de Reuil 27100, France. 3Johnson &
Johnson Santé Beauté France, 1 rue Camille Desmoulins, Issy-les-Moulineaux
92787, France.
Received: 24 April 2013 Accepted: 12 November 2013
Published: 18 November 2013References
1. Wanke I, Steffen H, Christ C, Krismer B, Gotz F, Peschel A, Schaller M,
Schittek B: Skin commensals amplify the innate immune response to
pathogens by activation of distinct signaling pathways. J Invest Dermatol
2011, 131:382–390.
2. Grange PA, Chereau C, Raingeaud J, Nicco C, Weill B, Dupin N, Batteux F:
Production of superoxide anions by keratinocytes initiates P. acnes-induced
inflammation of the skin. PLoS Pathog 2009, 5:e1000527.
3. Pivarcsi A, Nagy I, Kemeny L: Innate immunity in the skin: how
keratinocytes fight against pathogens. Curr Immunol Rev 2005, 1:29–42.
4. Cogen AL, Yamasaki K, Sanchez KM, Dorschner RA, Lai Y, MacLeod DT,
Torpey JW, Otto M, Nizet V, Kim JE, Gallo RL: Selective antimicrobial action
is provided by phenol-soluble modulins derived from Staphylococcus
epidermidis, a normal resident of the skin. J Invest Dermatol 2010,
130:192–200.
5. Lai Y, Cogen AL, Radek KA, Park HJ, Macleod DT, Leichtle A, Ryan AF, Di
Nardo A, Gallo RL: Activation of TLR2 by a small molecule produced by
Staphylococcus epidermidis increases antimicrobial defense against
bacterial skin infections. J Invest Dermatol 2010, 130:2211–2221.
6. Capone KA, Dowd SE, Stamatas GN, Nikolovski J: Diversity of the human
skin microbiome early in life. J Invest Dermatol 2011, 131:2026–2032.
7. Marchini G, Nelson A, Edner J, Lonne-Rahm S, Stavreus-Evers A, Hultenby K:
Erythema toxicum neonatorum is an innate immune response to
commensal microbes penetrated into the skin of the newborn infant.
Pediatr Res 2005, 58:613–616.
8. Naik S, Bouladoux N, Wilhelm C, Molloy MJ, Salcedo R, Kastenmuller W,
Deming C, Quinones M, Koo L, Conlan S, et al: Compartmentalized control
of skin immunity by resident commensals. Science 2012, 337:1115–1119.
9. Grice EA, Kong HH, Conlan S, Deming CB, Davis J, Young AC, Bouffard GG,
Blakesley RW, Murray PR, Green ED, et al: Topographical and temporal
diversity of the human skin microbiome. Science 2009, 324:1190–1192.
10. Henderson CA, Taylor J, Cunliffe WJ: Sebum excretion rates in mothers
and neonates. Br J Dermatol 2000, 142:110–111.
11. Nikolovski J, Stamatas GN, Kollias N, Wiegand BC: Barrier function and
water-holding and transport properties of infant stratum corneum are
different from adult and continue to develop through the first year of
life. J Invest Dermatol 2008, 128:1728–1736.
12. Hoeger PH, Enzmann CC: Skin physiology of the neonate and young
infant: a prospective study of functional skin parameters during early
infancy. Pediatr Dermatol 2002, 19:256–262.
13. Charles AJ: Superficial cutaneous fungal infections in tropical countries.
Dermatol Ther 2009, 22:550–559.
14. Bruggemann H: Insights in the pathogenic potential of
Propionibacterium acnes from its complete genome. Semin Cutan Med
Surg 2005, 24:67–72.
15. Kong HH: Skin microbiome: genomics-based insights into the diversity
and role of skin microbes. Trends Mol Med 2011, 17:320–328.
16. Balci DD, Duran N, Ozer B, Gunesacar R, Onlen Y, Yenin JZ: High prevalence
of Staphylococcus aureus cultivation and superantigen production in
patients with psoriasis. Eur J Dermatol 2009, 19:238–242.
17. Cogen AL, Nizet V, Gallo RL: Skin microbiota: a source of disease or
defence? Br J Dermatol 2008, 158:442–455.
18. Stamatas GN, Nikolovski J, Luedtke MA, Kollias N, Wiegand BC: Infant skin
microstructure assessed in vivo differs from adult skin in organization
and at the cellular level. Pediatr Dermatol 2010, 27:125–131.
Duckney et al. BMC Research Notes 2013, 6:474 Page 10 of 10
http://www.biomedcentral.com/1756-0500/6/47419. Jarrousse V, Castex-Rizzi N, Khammari A, Charveron M, Dreno B: Modulation
of integrins and filaggrin expression by Propionibacterium acnes extracts
on keratinocytes. Arch Dermatol Res 2007, 299:441–447.
20. Akaza N, Akamatsu H, Kishi M, Mizutani H, Ishii I, Nakata S, Matsunaga K:
Effects of Propionibacterium acnes on various mRNA expression levels in
normal human epidermal keratinocytes in vitro. J Dermatol 2009,
36:213–223.
21. Coquette A, Berna N, Vandenbosch A, Rosdy M, De Wever B, Poumay Y:
Analysis of interleukin-1alpha (IL-1alpha) and interleukin-8 (IL-8) expression
and release in in vitro reconstructed human epidermis for the prediction of
in vivo skin irritation and/or sensitization. Toxicol In Vitro 2003, 17:311–321.
22. Reichel M, Heisig P, Kampf G: Identification of variables for aerobic
bacterial density at clinically relevant skin sites. J Hosp Infect 2011,
78:5–10.
23. Hanakawa Y, Schechter NM, Lin C, Garza L, Li H, Yamaguchi T, Fudaba Y,
Nishifuji K, Sugai M, Amagai M, Stanley JR: Molecular mechanisms of
blister formation in bullous impetigo and staphylococcal scalded skin
syndrome. J Clin Invest 2002, 110:53–60.
24. Eckert RL, Sturniolo MT, Broome AM, Ruse M, Rorke EA: Transglutaminase
function in epidermis. J Invest Dermatol 2005, 124:481–492.
25. Sandilands A, Sutherland C, Irvine AD, McLean WH: Filaggrin in the
frontline: role in skin barrier function and disease. J Cell Sci 2009,
122:1285–1294.
26. de Koning HD, van den Bogaard EH, Bergboer JG, Kamsteeg M, van
Vlijmen-Willems IM, Hitomi K, Henry J, Simon M, Takashita N, Ishida-Yamamoto
A, et al: Expression profile of cornified envelope structural proteins and
keratinocyte differentiation-regulating proteins during skin barrier repair.
Br J Dermatol 2012, 166:1245–1254.
27. Ohnemus U, Kohrmeyer K, Houdek P, Rohde H, Wladykowski E, Vidal S,
Horstkotte MA, Aepfelbacher M, Kirschner N, Behne MJ, et al: Regulation of
epidermal tight-junctions (TJ) during infection with exfoliative toxin-negative
Staphylococcus strains. J Invest Dermatol 2008, 128:906–916.
28. Lai Y, Di Nardo A, Nakatsuji T, Leichtle A, Yang Y, Cogen AL, Wu ZR, Hooper
LV, Schmidt RR, von Aulock S, et al: Commensal bacteria regulate toll-like
receptor 3-dependent inflammation after skin injury. Nat Med 2009,
15:1377–1382.
doi:10.1186/1756-0500-6-474
Cite this article as: Duckney et al.: The role of the skin barrier in
modulating the effects of common skin microbial species on the
inflammation, differentiation and proliferation status of epidermal
keratinocytes. BMC Research Notes 2013 6:474.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
